Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved LINZESS® (linaclotide) as a once-daily ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

President Donald Trump said he takes more aspirin daily than his doctors recommend, continuing the routine for years and referring to it as a “superstition.” “They say aspirin is good for thinning out ...

1 Ironwood’s U.S. collaborative arrangements revenue includes reimbursement from AbbVie for a portion of Ironwood’s commercial expenses related to sales of LINZESS in the U.S. The FY2025 total revenue ...

Despite his doctors’ recommendations, President Trump takes a high dose. By Nina Agrawal President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical ...

• Skipping antibiotic doses can lower drug levels and reduce effectiveness. • Missing doses—especially multiple—can slow recovery and raise antibiotic resistance risk. • Don’t double doses; take a ...

Findings showed 30% of patients taking linaclotide 145mcg achieved the primary endpoint of combined responder. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Ironwood Pharmaceuticals IRWD reported adjusted earnings of 24 cents per share for the third quarter of 2025, which comprehensively beat the Zacks Consensus Estimate of 9 cents. The company had ...

Pediatric gastroenterologists now have a newly approved treatment option for children and adolescents with irritable bowel syndrome with constipation (IBS-C) following the FDA’s recent approval of ...